Viewbix Inc. (VBIX) director adds stock and pre-funded warrants

Rhea-AI Filing Summary

Viewbix Inc. director Yoresh Eliyahu acquired equity in the company through a share exchange with Quantum X Labs Ltd. On March 4, 2026, he received 179,159 shares of common stock and pre-funded warrants to purchase up to 88,675 additional common shares under a Securities Exchange Agreement.

The pre-funded warrants carry an exercise price of $0.0001 per share and will not expire until exercised in full. The filing also lists 2,518 common shares held indirectly through Yoresh Capital Ltd., which are reported for informational purposes with no new transaction in those securities.

Insider Trade Summary

3 transactions reported

Net Buy 3 txns

Insider Yoresh Eliyahu

Role Director

Bought 267,834 shs ($0.00)

Type	Security	Shares	Price	Value
Purchase	Pre-Funded Warrant to purchase common stock	88,675	$0.00	--
Purchase	Common Stock, par value $0.0001 per share	179,159	$0.00	--
holding	Common Stock, par value $0.0001 per share	--	--	--

Holdings After Transaction: Pre-Funded Warrant to purchase common stock — 88,675 shares (Direct); Common Stock, par value $0.0001 per share — 347,276 shares (Direct); Common Stock, par value $0.0001 per share — 2,518 shares (Indirect, By Yoresh Capital Ltd.)

Footnotes (1)

1. On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. These securities are held by Yoresh Capital Ltd. The Reporting Person is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. The Pre-Funded Warrants will not expire until exercised in full.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yoresh Eliyahu

(Last) (First) (Middle)

5 RABIN STREET

(Street)

KIRYAT ONO L3 5551010

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Viewbix Inc. [ VBIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	03/04/2026		P		179,159(1)	A	(1)	347,276	D
Common Stock, par value $0.0001 per share								2,518	I	By Yoresh Capital Ltd.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Pre-Funded Warrant to purchase common stock	$0.0001	03/04/2026		P		88,675(1)		03/04/2026	(3)	Common Stock	88,675	(1)	88,675	D

Explanation of Responses:

1. On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended.

2. These securities are held by Yoresh Capital Ltd. The Reporting Person is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

3. The Pre-Funded Warrants will not expire until exercised in full.

	/s/ Eliyahu Yoresh	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Viewbix Inc. (VBIX) director Yoresh Eliyahu acquire in this Form 4?

He acquired 179,159 shares of Viewbix common stock and pre-funded warrants for up to 88,675 additional shares. These securities were issued as consideration in a share exchange with Quantum X Labs Ltd., not as an open-market cash purchase.

How did Yoresh Eliyahu obtain the new Viewbix (VBIX) shares and warrants?

He received them in exchange for his shares in Quantum X Labs Ltd. under a Securities Exchange Agreement dated December 15, 2025. The transactions relied on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.

What are the key terms of the Viewbix (VBIX) pre-funded warrants reported?

The pre-funded warrants allow purchase of up to 88,675 Viewbix common shares at an exercise price of $0.0001 per share. According to the filing, these warrants will not expire and remain outstanding until they are exercised in full.

Were any Viewbix (VBIX) shares reported as indirectly owned by an entity?

Yes. The filing shows 2,518 Viewbix common shares held by Yoresh Capital Ltd., an entity controlled by Yoresh Eliyahu. He may be deemed a beneficial owner but disclaims beneficial ownership except for his pecuniary interest; these are included for informational purposes only.

Was there an open-market purchase of Viewbix (VBIX) shares in this Form 4?

No. Although the transaction code is a purchase, the footnotes clarify the shares and pre-funded warrants were issued in a private share exchange with Quantum X Labs Ltd., conducted under a registration exemption rather than through an open-market transaction.